Screener
United Therapeutics UTHR Retained Earnings Accumulated Deficit
Retained Earnings Accumulated Deficit at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's retained earnings accumulated deficit?
- United Therapeutics (UTHR) reported retained earnings accumulated deficit of $9.16B in Q2 2026.
- How has United Therapeutics's retained earnings accumulated deficit changed year-over-year?
- United Therapeutics's retained earnings accumulated deficit increased by 16.7% year-over-year, from $7.85B to $9.16B.
- What is the long-term trend for United Therapeutics's retained earnings accumulated deficit?
- Over 5 years (2020 to 2025), United Therapeutics's retained earnings accumulated deficit has grown at a 17.4% compound annual growth rate (CAGR), from $3.84B to $8.56B.
- What does retained earnings accumulated deficit mean?
- Retained Earnings Accumulated Deficit as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's retained earnings accumulated deficit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude